Privia Health investors back all 2026 proposals
Privia Health Group, Inc. reported the results of its 2026 Annual Meeting of Stockholders, where all proposals were approved.
Rhea-AI Filing Summary
Privia Health Group, Inc. reported the results of its 2026 Annual Meeting of Stockholders, where all proposals were approved. Stockholders elected three Class I directors — Nancy Cocozza, David King, and Francis Soistman — to terms running until the 2029 annual meeting.
Stockholders also approved, on an advisory and non-binding basis, the compensation of the company’s named executive officers, with 103,956,500 votes cast in favor. In addition, the appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026 received strong support, with 117,343,159 votes for and minimal opposition.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 5.07 — Submission of Matters to a Vote of Security Holders
1 item
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Key Figures
Votes for Nancy Cocozza: 103,661,977 votes
Votes for David King: 99,267,027 votes
Votes for Francis Soistman: 105,602,389 votes
+3 more
6 metrics
Votes for Nancy Cocozza
103,661,977 votes
Election as Class I director at 2026 annual meeting
Votes for David King
99,267,027 votes
Election as Class I director at 2026 annual meeting
Votes for Francis Soistman
105,602,389 votes
Election as Class I director at 2026 annual meeting
Say-on-pay votes for
103,956,500 votes
Advisory approval of named executive officer compensation
Say-on-pay votes against
1,813,934 votes
Advisory approval of named executive officer compensation
Auditor ratification votes for
117,343,159 votes
Ratification of PricewaterhouseCoopers LLP for fiscal 2026
Key Terms
Annual Meeting of Stockholders, Class I directors, advisory (non-binding) basis, broker non-votes, +1 more
5 terms
Annual Meeting of Stockholders regulatory
"On May 20, 2026, Privia Health Group, Inc. held its 2026 Annual Meeting of Stockholders"
Class I directors regulatory
"three nominees were elected to serve as Class I directors for a term expiring"
Class I directors are the subset of a company’s board whose terms expire at a specific annual meeting under a staggered election system that divides directors into multiple groups with different re-election years. For investors this matters because staggered classes slow how quickly shareholders can replace the board, affecting takeover risk, governance change and the pace of corporate decisions — like rotating only part of a team instead of swapping everyone at once.
advisory (non-binding) basis regulatory
"Approval, on an advisory (non-binding) basis, of the compensation of our named executive officers"
broker non-votes financial
"Votes For, Votes Against, Abstentions, Broker Non-Votes"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
independent registered public accounting firm regulatory
"Ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Which directors were elected at Privia Health’s 2026 annual meeting?
Shareholders elected Nancy Cocozza, David King, and Francis Soistman as Class I directors. Each will serve until the 2029 annual meeting, or until a successor is duly elected and qualified or earlier death, resignation, or removal under the company’s governance framework.
How did Privia Health (PRVA) stockholders vote on executive compensation?
Stockholders approved the compensation of Privia Health’s named executive officers on a non-binding advisory basis. The proposal received 103,956,500 votes for, 1,813,934 against, and 105,446 abstentions, with 11,549,510 broker non-votes recorded in the tally.
Was PricewaterhouseCoopers ratified as Privia Health’s auditor for 2026?
Yes. Shareholders ratified PricewaterhouseCoopers LLP as Privia Health’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The proposal received 117,343,159 votes for, 8,578 against, and 73,653 abstentions, with no broker non-votes reported.
What were the vote totals for Privia Health’s say-on-pay proposal in 2026?
The advisory say-on-pay proposal received 103,956,500 votes for and 1,813,934 against. There were 105,446 abstentions and 11,549,510 broker non-votes, indicating broad but not unanimous support for the company’s named executive officer compensation program.
How strong was support for Privia Health’s 2026 director nominees?
Support was high for all three Class I nominees. For example, Nancy Cocozza received 103,661,977 votes for, and Francis Soistman received 105,602,389 votes for, alongside relatively low withheld votes and 11,549,510 broker non-votes on each director proposal.
AI-generated analysis. How Rhea-AI works. Not financial advice.
